Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00148798
Status:
COMPLETED
Last Update Posted:
2014-06-25
First Post:
2005-09-07
Brief Title:
Study of CisplatinVinorelbine - Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer FLEX
Sponsor:
Merck KGaA Darmstadt Germany
Organization:
Merck KGaA Darmstadt Germany
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-10
Start Date Type:
None
Primary Completion Date:
2007-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-05
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-07
First Submit QC Date:
September 7 2005
Study First Post Date:
2005-09-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2011-10-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-06-13
Last Update Post Date:
2014-06-25
Last Update Post Date Type:
ESTIMATED